Athens Medical C.S.A. (IATR) — Capital Reinvestment Ratio
Latest as of June 2023:
1.64x
Athens Medical C.S.A. (IATR) has a Capital Reinvestment Ratio of 1.64x as of June 2023, meaning it reinvests 2% of its operating cash flow (€3.17 Million) in capital expenditures (€5.19 Million). See Athens Medical C.S.A. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.64x
Capex / Operating Cash Flow
Operating Cash Flow
€3.17 Million
EUR
Capital Expenditures
€5.19 Million
EUR
Data as of
Jun 2023
Most recent filing
Athens Medical C.S.A. Capital Reinvestment Ratio (2014–2024)
This chart tracks Athens Medical C.S.A.'s Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Athens Medical C.S.A. (2014–2024)
Year-by-year Capital Reinvestment Ratio for Athens Medical C.S.A. from 2014 to 2024. For live market cap and broader valuation context, see IATR market cap.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.57x | €46.44 Million | €26.63 Million | ▼ -33.0% |
| 2023 | 0.86x | €26.13 Million | €22.35 Million | ▼ -99.3% |
| 2022 | 128.02x | €124.00K | €15.87 Million | ▲ +17767.6% |
| 2021 | 0.72x | €15.75 Million | €11.28 Million | ▲ +307.0% |
| 2020 | 0.18x | €40.21 Million | €7.08 Million | ▼ -65.9% |
| 2019 | 0.52x | €31.50 Million | €16.27 Million | ▲ +29.9% |
| 2018 | 0.40x | €20.02 Million | €7.96 Million | ▲ +3.1% |
| 2016 | 0.39x | €9.78 Million | €3.77 Million | ▲ +147.2% |
| 2015 | 0.16x | €12.89 Million | €2.01 Million | ▼ -81.4% |
| 2014 | 0.84x | €3.58 Million | €3.00 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow